- Home
- Equipment
- usa california
- breast cancer
Refine by
Applications
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
Breast Cancer Equipment Supplied In Usa California
24 equipment items found
Manufactured by:Veracyte, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Using prognostic information to inform next steps in patient care. The Prosigna Breast Cancer Prognostic Gene Signature Assay uses advanced genomic technology to inform next steps for patients with early-stage breast cancer, based on the genomic make-up of their disease. The test analyzes the activity of 50 genes known as the ...
Manufactured by:Novodiax, Inc. based inHayward, CALIFORNIA (USA)
Pan Cytokeratin (CK) AE1/AE3 cocktail is a polymerized horseradish peroxidase (pHRP)-labeled anti human Pan CK (Clone AE1/AE3) antibody intended for laboratory use to qualitatively identify by light microscopy the presence of cytokeratins which are expressed in tissues of epithelial origin, including squamous and glandular epithelial cells, in sections of formalin-fixed, paraffin-embedded (FFPE) ...
Manufactured by:Novodiax, Inc. based inHayward, CALIFORNIA (USA)
Polymerized horseradish peroxidase (pHRP)-labeled anti-human Cytokeratin 8/18 (CK 8/18) antibody (Cytokeratin 8/18 pHRP) is intended for laboratory use to qualitatively identify by light microscopy the presence of CK 8/18 in sections of formalin-fixed, paraffin-embedded tissue sections or frozen tissues using immunohistochemistry (IHC) test methods. The clinical interpretation of any staining or ...
Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)
CD166 is a molecule widely and highly expressed on solid tumor cells and previously considered “undruggable” given its expression on normal tissues. In preclinical studies, Probody drug conjugates targeting CD166, have led to complete regressions in models of breast and lung cancer at therapeutically relevant doses, and are well tolerated in non-human ...
Manufactured by:CMR Naviscan Corporation based inCarlsbad, CALIFORNIA (USA)
The LumaGEM® Molecular Breast Imaging system’s patented mounting mechanism allows the use of light breast immobilization for greater patient comfort during breast cancer imaging exam. The LumaGEM MBI system for breast cancer imaging visually illuminates the enhanced metabolic activity ...
Manufactured by:Time Medical Holding based inShatin, CHINA
The EMMA 1.5T MRI is designed to offer breast imaging centers a new adjunctive tool to their current equipment options. Emma is a whole body MRI with dedicated breast coils for exclusive high-quality imaging. In collaboration with leading breast cancer centers and following new published trends, the EMMA system extends MRI's ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
Xoft offers patients and physicians a simplified alternative to traditional six-week radiation therapy for early-stage breast cancer treatment. With the Xoft Axxent Electronic Brachytherapy (eBx) System, delivery of radiation therapy in the operating room at the time of surgery is possible with intraoperative radiation therapy ...
Manufactured by:Cell Applications, Inc. based inSan Diego, CALIFORNIA (USA)
Differentiated HAd from Cell Applications, Inc. have been used to identify genetic elements responsible for aromatase production (and consequently, elevated plasma estrogen) in postmenopausal breast cancer patients. ...
Manufactured by:EntroGen, Inc. based inWoodland Hills, CALIFORNIA (USA)
It has a central role in the PI3K-AKT-mTOR pathway. Somatic mutations in the PIK3CA gene have been implicated in the pathogenesis of several cancers, including colon cancer, gliomas, gastric cancer, breast cancer, endometrial cancer, and lung cancer. PIK3CA mutations commonly ...
Manufactured by:T-Cure BioScience, Inc. based inSherman Oaks, CALIFORNIA (USA)
The Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) that is expressed in multiple solid tumors while restricted to germ line cells in normal tissues. T-Cure estimates that KK-LC-1 is expressed in 80% gastric cancer, 75% triple negative breast cancer (TNBC), 45% non-small cell lung ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
We are passionate about targeted cancer care expertly tailored to meet patients’ personalized needs. We designed the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to empower physicians with full confidence to precisely and effectively treat cancer and enable their patients to live healthy, high-quality lives. Xoft offers patients ...
Manufactured by:Qualigen Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
QN-247, formerly referred to as ALAN (Aptamer Linked Anti Nucleolin), is an aptamer-based investigational drug candidate currently under development and evaluation with the potential to treat a variety of different cancer types, including liquid and solid tumors. A key component of this drug candidate, the QN-165 aptamer, has been tested in over 100 cancer ...
Manufactured by:Illumina Inc. based inSan Diego, CALIFORNIA (USA)
Targeted research panel investigating somatic and germline variants in BRCA1 and ...
Manufactured by:PreludeDx based inLaguna Hills, CALIFORNIA (USA)
BREAST SOS a second opinion service, to verify, modify if needed, and help you better understand your ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ MicroOrganoSphereTM powers the only assay which can provide oncologists with accurate results of drug sensitivity on a patient’s own tumor within the clinical decision-making window - finally realizing the promise of precision medicine. Xilis is developing a panel of disease specific assays systematically testing the most important standard-of-care drugs within equipoise or ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent® Electronic Brachytherapy (eBx) System utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
Our proprietary, miniaturized x-ray source is isotope-free and operates at 50 kV to deliver high dose rate, low energy radiation. The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others ...
Manufactured by:EntroGen, Inc. based inWoodland Hills, CALIFORNIA (USA)
BRCA Complete Expanded Panel is a complete next generation sequencing (NGS) solution for detecting clinically relevant BRCA1 and BRCA2 mutations along with extended coverage of CHEK2, PALB2, RAD51C and TP53. ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent Electronic Brachytherapy (eBx) System utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers. The Xoft System provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy ...